Results 211 to 220 of about 1,444,385 (351)
Performance assessment of DNA sequencing platforms in the ABRF Next-Generation Sequencing Study
J. Foox +26 more
semanticscholar +1 more source
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad +17 more
wiley +1 more source
Monitoring Variant Allele Fraction in VEXAS Syndrome: A Comparison of Digital PCR and Next-Generation Sequencing. [PDF]
Exposito-Bey A +4 more
europepmc +1 more source
Error filtering, pair assembly and error correction for next-generation sequencing reads
Robert C. Edgar, H. Flyvbjerg
semanticscholar +1 more source
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
The utility of next-generation sequencing in metastatic prostate cancer FNA biopsies. [PDF]
Sirohi D +7 more
europepmc +1 more source
Compression of Next-Generation Sequencing Data and of DNA Digital Files [PDF]
Bruno Carpentieri
openalex +1 more source
In over 50% of non‐metastatic breast cancer patients, circulating tumor cells (CTCs) along the whole epithelial‐mesenchymal transition spectrum are detected. Total CTC number and individual phenotypes relate to aggressive disease characteristics, including lymph node involvement and higher tumor proliferation. At the single‐cell level, mesenchymal CTCs
Justyna Topa +14 more
wiley +1 more source

